Latest Administration News

Page 62 of 135
Trigg Minerals has acquired 100% of the Tennessee Mountain Tungsten Project in Nevada, marking a strategic expansion into critical minerals with a historically significant tungsten resource. The move aligns with rising tungsten demand and the company's goal to become a key supplier of defence metals.
Maxwell Dee
Maxwell Dee
7 Aug 2025
AMP reported a 9.2% increase in underlying net profit after tax to $131 million for the first half of 2025, driven by robust cashflow growth and steady performances across its wealth and banking divisions. The company also declared a 2.0 cents per share interim dividend, maintaining disciplined cost control amid ongoing strategic investments.
Claire Turing
Claire Turing
7 Aug 2025
Toys"R"Us ANZ has formalised a Deed of Company Arrangement, paving the way for Directed Electronics Australia to acquire the company and trigger its delisting from the ASX.
Logan Eniac
Logan Eniac
6 Aug 2025
Finexia Financial Group has ended talks on a major disposal deal and is managing loan defaults with fresh collateral, while expanding its childcare lending strategy.
Claire Turing
Claire Turing
6 Aug 2025
Nyrada’s Phase I clinical trial for Xolatryp™ concludes with positive safety and pharmacokinetic results, paving the way for a Phase IIa study in acute myocardial infarction patients.
Ada Torres
Ada Torres
6 Aug 2025
Nanosonics has secured FDA clearance for its next-generation trophon3 device and trophon2 Plus software upgrade, setting the stage for significant growth in the US medical disinfection market.
Ada Torres
Ada Torres
6 Aug 2025
Nutritional Growth Solutions revises its Q2 FY25 financials, confirming stable revenue and detailing expanded distribution into CVS and Walmart. The company is actively raising capital to support growth and improve liquidity.
Victor Sage
Victor Sage
5 Aug 2025
ChemX Materials Limited has explained the delayed filing of director interest notices, attributing it to transitional challenges during its recent recapitalisation and governance overhaul.
Maxwell Dee
Maxwell Dee
5 Aug 2025
Immutep has received encouraging feedback from the FDA on its immunotherapy eftilagimod alfa combined with KEYTRUDA for patients with low PD-L1 expression in head and neck cancer, opening potential accelerated approval pathways.
Ada Torres
Ada Torres
5 Aug 2025
Coventry Group’s FY25 results reveal a sharp EBITDA decline amid ERP disruptions and soft markets, prompting a major cost reduction drive for FY26.
Victor Sage
Victor Sage
5 Aug 2025
Macro Metals Limited has successfully raised A$2 million through a share placement, positioning itself to accelerate exploration and expand its mining services operations.
Maxwell Dee
Maxwell Dee
5 Aug 2025
Vitrafy Life Sciences reported a $32.7 million loss for FY25, driven by investments in its next-generation cryopreservation platform following a $35 million IPO and a $4.8 million government grant. The company is progressing commercialization efforts with key partnerships in human and animal health.
Ada Torres
Ada Torres
5 Aug 2025